Peptides & HGH

KIgtropin 200 IU Biotechnology Co Ltd

Co Ltd

255,00

In Stock (100 available)

KIgtropin 200 IU Co Ltd (200 iu) — Human Growth Hormone is the cornerstone of elite-level physique development and anti-aging medicine. Its unique ability to promote…

100 in stock

This product is for laboratory research use only. Not for human consumption.

5+ −10%
10+ −15% Best price
Third-Party Lab Report HPLC verified
CoA available on request — email support@vitalquests.org with the batch code from your vial.
HPLC TestedBatch report available
No Labels on BoxPlain brown parcel
Pay the CourierCash on delivery only
Ships TodayOrder before 14:00
€85+ = free shipping
EU warehouse — no customs, no delays
Tracked via DHL / DPD / InPost
Categories: ,

Description

KIgtropin 200 IU Co Ltd — recombinant human growth hormone from Co Ltd at 200 iu. Drives IGF-1 production and downstream anabolism. Cold-chain 2–8°C storage required. Minimum 3–6 months for meaningful results.

Key Benefits

  • Recombinant 191-amino-acid sequence — identical to pituitary HGH
  • Mobilises visceral fat, improves recovery, thickens connective tissue
  • Long-game compound — 3–6 month commitment minimum
  • Does not suppress HPTA, does not aromatise
  • Cold-chain storage after reconstitution; lyophilised vial stable at 2–8 °C
  • Each unit dosed at 200 IU — see Recommended Dosage below for protocol-specific intake

Recommended Dosage

Research dosing: fat-loss / recovery 2–3 IU/day SubQ AM; bodybuilding 4–6 IU/day; anti-aging 1–2 IU/day. Morning dosing on empty stomach maximises lipolytic window. Cycles 3–6 months minimum — effects are cumulative, not acute.

How It Works

Recombinant growth hormone (somatotropin), 191-amino-acid single-chain polypeptide produced via E. coli expression. Binds pituitary-axis-independent GH receptors; liver converts to IGF-1 (primary mediator of growth effects). Drives lipolysis, collagen synthesis, and satellite-cell recruitment.

Pharmacokinetics

HGH plasma half-life ~2–3 hours; IGF-1 signalling downstream persists 12–16 hours — hence once-daily dosing produces clinical effect despite short serum residency. Reconstituted vial stable 2–8 °C for 14 days.

Potential Side Effects

Dose-dependent: 1–3 IU/day well-tolerated; 4 IU+/day water retention, carpal-tunnel symptoms, insulin resistance risk. Fasting glucose monitoring quarterly on extended runs. HbA1c at month 3. Insulin resistance the main long-run concern above 4 IU.

Cycle & Stacking Guide

3–6 month protocols. Stacks cleanly with TRT, blasts, and peptide secretagogues. Target IGF-1 on 2.5 IU/day: 250–350 ng/mL. Pull IGF-1 at week 8 to verify product activity — if still baseline (~150 ng/mL), either dose too low or product underdosed.

Manufacturer Notes

Co Ltd is an independent producer in the research-compound market. Before first use, request the batch-specific Certificate of Analysis and confirm the vial’s tamper-evident seal is intact.

Storage & Handling

Pre-reconstitution: store at 2–8 °C, protected from freezing and light. Post-reconstitution: use within 14–21 days, maintained at 2–8 °C throughout. Never freeze reconstituted solution — freezing irreversibly denatures the protein. Transport in an insulated cold-pack for trips. Keep out of reach of children. For research and educational purposes only.

Reviews

There are no reviews yet.

Be the first to review “KIgtropin 200 IU Biotechnology Co Ltd”

Your email address will not be published. Required fields are marked *